| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 2.41e-08 | 9 | 76 | 4 | GO:0015379 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 9.37e-08 | 12 | 76 | 4 | GO:0008519 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.62e-06 | 23 | 76 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 2.72e-06 | 26 | 76 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 9.11e-05 | 119 | 76 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | symporter activity | 2.69e-04 | 150 | 76 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.17e-04 | 165 | 76 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 4.41e-04 | 167 | 76 | 5 | GO:0015079 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 5.14e-04 | 97 | 76 | 4 | GO:0004896 | |
| GeneOntologyMolecularFunction | guanylate kinase activity | 7.69e-04 | 11 | 76 | 2 | GO:0004385 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 1.09e-03 | 13 | 76 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.33e-03 | 125 | 76 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IL12RB1 IL13RA1 TNFRSF25 NPBWR2 OR10A2 GLP1R IL20RB GPR55 PTGER3 VN1R1 ADCYAP1R1 IL27RA LILRA4 | 1.67e-03 | 1353 | 76 | 13 | GO:0004888 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.95e-03 | 465 | 76 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.01e-03 | 140 | 76 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.10e-03 | 18 | 76 | 2 | GO:0004016 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 1.06e-07 | 13 | 74 | 4 | GO:0072488 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 1.77e-07 | 4 | 74 | 3 | GO:0140157 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 1.82e-06 | 25 | 74 | 4 | GO:0055064 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 2.93e-06 | 28 | 74 | 4 | GO:0055081 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 9.22e-06 | 37 | 74 | 4 | GO:0055075 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC12A6 SLC35G1 SLC12A4 GLP1R LRRC26 SLC6A5 UBR3 SLC12A7 PTGER3 HEPH ADCYAP1R1 RYR3 SLC12A5 CASK | 1.09e-05 | 1000 | 74 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 1.54e-05 | 42 | 74 | 4 | GO:0006884 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 3.36e-05 | 51 | 74 | 4 | GO:1990573 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 SLC35G1 SLC12A4 GLP1R LRRC26 SLC6A5 UBR3 SLC12A7 PTGER3 HEPH ADCYAP1R1 RYR3 SLC12A5 CASK | 5.45e-05 | 1157 | 74 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | proteasomal ubiquitin-independent protein catabolic process | 7.58e-05 | 4 | 74 | 2 | GO:0010499 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 SLC35G1 SLC12A4 GLP1R LRRC26 SLC6A5 UBR3 SLC12A7 PTGER3 ADCYAP1R1 RYR3 SLC12A5 | 1.01e-04 | 922 | 74 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 SLC35G1 SLC12A4 GLP1R LRRC26 SLC6A5 UBR3 SLC12A7 PTGER3 ADCYAP1R1 RYR3 SLC12A5 | 1.23e-04 | 942 | 74 | 12 | GO:0098655 |
| GeneOntologyBiologicalProcess | cAMP-mediated signaling | 1.61e-04 | 76 | 74 | 4 | GO:0019933 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 1.86e-04 | 232 | 74 | 6 | GO:0071805 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 1.89e-04 | 6 | 74 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 1.89e-04 | 6 | 74 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 SLC35G1 SLC12A4 GLP1R LRRC26 SLC6A5 UBR3 SLC12A7 PTGER3 ADCYAP1R1 RYR3 SLC12A5 | 2.51e-04 | 1017 | 74 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 SLC35G1 SLC12A4 GLP1R LRRC26 SLC6A5 UBR3 SLC12A7 PTGER3 HEPH ADCYAP1R1 RYR3 SLC12A5 CASK | 3.32e-04 | 1374 | 74 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | type II interferon production | 3.55e-04 | 169 | 74 | 5 | GO:0032609 | |
| GeneOntologyBiologicalProcess | learning or memory | 3.80e-04 | 373 | 74 | 7 | GO:0007611 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 4.35e-04 | 272 | 74 | 6 | GO:0006813 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC12A6 SLC35G1 MLXIPL TLCD1 SLC12A4 GLP1R INSIG1 ACSM1 PKHD1 SLC12A7 SLC66A1 RYR3 SLC12A5 | 4.56e-04 | 1249 | 74 | 13 | GO:0048878 |
| GeneOntologyBiologicalProcess | regulation of G protein-coupled receptor signaling pathway | 4.86e-04 | 181 | 74 | 5 | GO:0008277 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 5.61e-04 | 10 | 74 | 2 | GO:0070383 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 SLC35G1 SLC12A4 GLP1R LRRC26 SLC6A5 UBR3 SLC12A7 PTGER3 ADCYAP1R1 RYR3 SLC12A5 | 5.76e-04 | 1115 | 74 | 12 | GO:0034220 |
| Domain | KCL_cotranspt | 2.53e-10 | 4 | 76 | 4 | IPR000076 | |
| Domain | SLC12A_fam | 8.78e-09 | 7 | 76 | 4 | IPR004842 | |
| Domain | SLC12_C | 1.75e-08 | 8 | 76 | 4 | IPR018491 | |
| Domain | SLC12 | 1.75e-08 | 8 | 76 | 4 | PF03522 | |
| Domain | AA-permease/SLC12A_dom | 1.75e-06 | 22 | 76 | 4 | IPR004841 | |
| Domain | AA_permease | 1.75e-06 | 22 | 76 | 4 | PF00324 | |
| Domain | KCC1 | 1.63e-05 | 2 | 76 | 2 | IPR000622 | |
| Domain | DUSP | 2.43e-04 | 6 | 76 | 2 | SM00695 | |
| Domain | DUSP | 2.43e-04 | 6 | 76 | 2 | PF06337 | |
| Domain | - | 3.39e-04 | 7 | 76 | 2 | 3.30.2230.10 | |
| Domain | DUSP | 3.39e-04 | 7 | 76 | 2 | PS51283 | |
| Domain | Pept_C19_DUSP | 3.39e-04 | 7 | 76 | 2 | IPR006615 | |
| Domain | HEMATOPO_REC_L_F2 | 4.50e-04 | 8 | 76 | 2 | PS01353 | |
| Domain | ZnF_UBP | 8.78e-04 | 11 | 76 | 2 | SM00290 | |
| Domain | APOBEC_N | 1.05e-03 | 12 | 76 | 2 | PF08210 | |
| Domain | APOBEC_N | 1.05e-03 | 12 | 76 | 2 | IPR013158 | |
| Domain | Znf_UBP | 1.44e-03 | 14 | 76 | 2 | IPR001607 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.44e-03 | 14 | 76 | 2 | IPR016192 | |
| Domain | zf-UBP | 1.44e-03 | 14 | 76 | 2 | PF02148 | |
| Domain | ZF_UBP | 1.44e-03 | 14 | 76 | 2 | PS50271 | |
| Domain | - | IL12RB1 IL13RA1 CD33 VTCN1 PKHD1 IL20RB SIGLECL1 IL27RA LILRA4 | 1.45e-03 | 663 | 76 | 9 | 2.60.40.10 |
| Domain | Guanylate_kinase_CS | 1.89e-03 | 16 | 76 | 2 | IPR020590 | |
| Domain | A/G_cyclase_CS | 2.14e-03 | 17 | 76 | 2 | IPR018297 | |
| Domain | Cytidine_deaminase-like | 2.14e-03 | 17 | 76 | 2 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 2.14e-03 | 17 | 76 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 2.14e-03 | 17 | 76 | 2 | IPR002125 | |
| Domain | TSP_1 | 2.16e-03 | 63 | 76 | 3 | PF00090 | |
| Domain | Ig-like_fold | IL12RB1 IL13RA1 CD33 VTCN1 PKHD1 IL20RB SIGLECL1 IL27RA LILRA4 | 2.22e-03 | 706 | 76 | 9 | IPR013783 |
| Domain | TSP1 | 2.36e-03 | 65 | 76 | 3 | SM00209 | |
| Domain | TSP1_rpt | 2.36e-03 | 65 | 76 | 3 | IPR000884 | |
| Domain | TSP1 | 2.36e-03 | 65 | 76 | 3 | PS50092 | |
| Domain | Nucleotide_cyclase | 2.40e-03 | 18 | 76 | 2 | IPR029787 | |
| Domain | - | 2.40e-03 | 18 | 76 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 2.67e-03 | 19 | 76 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 2.67e-03 | 19 | 76 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 2.67e-03 | 19 | 76 | 2 | PS50125 | |
| Domain | A/G_cyclase | 2.67e-03 | 19 | 76 | 2 | IPR001054 | |
| Domain | CYCc | 2.67e-03 | 19 | 76 | 2 | SM00044 | |
| Domain | GUANYLATE_KINASE_2 | 3.91e-03 | 23 | 76 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 3.91e-03 | 23 | 76 | 2 | PS00856 | |
| Domain | HormR | 4.61e-03 | 25 | 76 | 2 | SM00008 | |
| Domain | Guanylate_kin | 4.99e-03 | 26 | 76 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 4.99e-03 | 26 | 76 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 4.99e-03 | 26 | 76 | 2 | IPR008144 | |
| Domain | GuKc | 4.99e-03 | 26 | 76 | 2 | SM00072 | |
| Domain | HRM | 5.77e-03 | 28 | 76 | 2 | PF02793 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.10e-08 | 7 | 61 | 4 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.10e-08 | 7 | 61 | 4 | MM15081 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 9.05e-06 | 10 | 61 | 3 | MM1530 | |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 7.11e-05 | 19 | 61 | 3 | M22004 | |
| Pubmed | 2.10e-11 | 4 | 76 | 4 | 12637262 | ||
| Pubmed | 1.46e-09 | 8 | 76 | 4 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 1.46e-09 | 8 | 76 | 4 | 24393035 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 1.46e-09 | 8 | 76 | 4 | 21613606 | |
| Pubmed | 2.63e-09 | 9 | 76 | 4 | 19323993 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 11551954 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 15262997 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 1.00e-08 | 3 | 76 | 3 | 21733850 | |
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 1.49e-07 | 22 | 76 | 4 | 18391953 | |
| Pubmed | USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. | 2.00e-07 | 6 | 76 | 3 | 23486064 | |
| Pubmed | 5.57e-07 | 8 | 76 | 3 | 12386165 | ||
| Pubmed | Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. | 8.34e-07 | 9 | 76 | 3 | 14532115 | |
| Pubmed | Differences in the large extracellular loop between the K(+)-Cl(-) cotransporters KCC2 and KCC4. | 4.71e-06 | 2 | 76 | 2 | 20516068 | |
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 4.71e-06 | 2 | 76 | 2 | 34031912 | |
| Pubmed | Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. | 4.71e-06 | 2 | 76 | 2 | 12106695 | |
| Pubmed | SLC12A ion transporter mutations in sporadic and familial human congenital hydrocephalus. | 4.71e-06 | 2 | 76 | 2 | 31393094 | |
| Pubmed | CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia. | 4.71e-06 | 2 | 76 | 2 | 32647856 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17510708 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10347194 | ||
| Pubmed | Disabled-2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion. | 4.71e-06 | 2 | 76 | 2 | 11823414 | |
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 4.71e-06 | 2 | 76 | 2 | 31835175 | |
| Pubmed | The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55. | 4.71e-06 | 2 | 76 | 2 | 21718301 | |
| Pubmed | Deubiquitinases USP20/33 promote the biogenesis of tail-anchored membrane proteins. | 4.71e-06 | 2 | 76 | 2 | 33792613 | |
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 1.41e-05 | 3 | 76 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 1.41e-05 | 3 | 76 | 2 | 27602762 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22397921 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31352162 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 1.41e-05 | 3 | 76 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 1.41e-05 | 3 | 76 | 2 | 24577894 | |
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 1.41e-05 | 3 | 76 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 1.41e-05 | 3 | 76 | 2 | 23533681 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 1541833 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 27356895 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 1.41e-05 | 3 | 76 | 2 | 25589647 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 1.41e-05 | 3 | 76 | 2 | 31518043 | |
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 1.41e-05 | 3 | 76 | 2 | 24840555 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 17133354 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 9765497 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 12865408 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24453360 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23449789 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 1.41e-05 | 3 | 76 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 1.41e-05 | 3 | 76 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 1.41e-05 | 3 | 76 | 2 | 18772436 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 35274823 | ||
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 1.41e-05 | 3 | 76 | 2 | 18786991 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 286744 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22252133 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24725948 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20702647 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20980520 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 284359 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20617165 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 1.41e-05 | 3 | 76 | 2 | 39208378 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31943071 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 12056827 | ||
| Pubmed | NudC-like protein 2 restrains centriole amplification by stabilizing HERC2. | 1.41e-05 | 3 | 76 | 2 | 31427565 | |
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 1.41e-05 | 3 | 76 | 2 | 20566830 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22102330 | ||
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 1.41e-05 | 3 | 76 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 1.41e-05 | 3 | 76 | 2 | 25505062 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31595054 | ||
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 1.41e-05 | 3 | 76 | 2 | 17967065 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20335265 | ||
| Pubmed | Molecular evidence for a role for K(+)-Cl(-) cotransporters in the kidney. | 1.41e-05 | 3 | 76 | 2 | 24089410 | |
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 1.41e-05 | 3 | 76 | 2 | 29593034 | |
| Pubmed | Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family. | 1.41e-05 | 3 | 76 | 2 | 12739168 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31830125 | ||
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 1.41e-05 | 3 | 76 | 2 | 21998583 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 1.41e-05 | 3 | 76 | 2 | 38115583 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 1.41e-05 | 3 | 76 | 2 | 35458563 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22275865 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 293683 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 19150103 | ||
| Pubmed | Ammonium transport and pH regulation by K(+)-Cl(-) cotransporters. | 1.41e-05 | 3 | 76 | 2 | 12657561 | |
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 1.41e-05 | 3 | 76 | 2 | 12466850 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 21525354 | ||
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 2.82e-05 | 4 | 76 | 2 | 18983852 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 2.82e-05 | 4 | 76 | 2 | 31400166 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 23725696 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 21985787 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 2.82e-05 | 4 | 76 | 2 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 2.82e-05 | 4 | 76 | 2 | 26253512 | |
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 2.82e-05 | 4 | 76 | 2 | 17020885 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 20375169 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 21147467 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 16055735 | ||
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 2.82e-05 | 4 | 76 | 2 | 18572219 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 16378963 | ||
| Pubmed | Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s. | 2.82e-05 | 4 | 76 | 2 | 32893454 | |
| Pubmed | Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. | 2.82e-05 | 4 | 76 | 2 | 15269786 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 2.82e-05 | 4 | 76 | 2 | 24821801 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 2.82e-05 | 4 | 76 | 2 | 20363737 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 2.82e-05 | 4 | 76 | 2 | 29343743 | |
| Pubmed | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | 2.82e-05 | 4 | 76 | 2 | 15674295 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 9.09e-06 | 42 | 57 | 4 | 602 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 6.32e-04 | 12 | 57 | 2 | 406 | |
| GeneFamily | Solute carriers | 1.48e-03 | 395 | 57 | 6 | 752 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.02e-03 | 26 | 57 | 2 | 904 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | COL4A4 SLC35G1 TNFRSF25 DNAH3 SERPINE3 INSIG1 ACSM1 IRF8 HEPH CASK | 5.83e-06 | 587 | 74 | 10 | M40869 |
| Coexpression | SRC_UP.V1_UP | 1.14e-05 | 178 | 74 | 6 | M2714 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN | 2.02e-05 | 197 | 74 | 6 | M5786 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | TICRR MLXIPL TCERG1L SLC12A4 SEMA5B GUCY2D DAB2 IRF8 ADAMTS5 SLC12A7 EN1 PTGER3 | 4.43e-05 | 1074 | 74 | 12 | M1941 |
| ToppCell | LPS_only-Endothelial-Epi-like|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.97e-08 | 126 | 76 | 6 | 4c598f7bae09aca7a4ecce63dfd6890b26468c73 | |
| ToppCell | LPS_only-Endothelial-Epi-like-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.97e-08 | 126 | 76 | 6 | e065304f480a5e38532b66508b0ee87cc48bba9b | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic|blood / Manually curated celltypes from each tissue | 5.54e-07 | 175 | 76 | 6 | 1c48eec300d5a6d4a810947b995af3b8c0a5a601 | |
| ToppCell | mild-Myeloid-pDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.54e-07 | 180 | 76 | 6 | 38614155fa537d0defda914c531c697be0ef06d8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.20e-07 | 183 | 76 | 6 | 4cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.69e-07 | 189 | 76 | 6 | 0a490730cdc912d5233de59057550de0e4065747 | |
| ToppCell | BLOOD--(3)_DC_(cDC+pDC)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.53e-07 | 192 | 76 | 6 | e290c55a1321e9e577f49e8ba20501b2c8150044 | |
| ToppCell | severe-Myeloid-pDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.30e-06 | 161 | 76 | 5 | 9e8e8ac11f7fb8c8697357c21034b613f191db2b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.62e-06 | 166 | 76 | 5 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.08e-05 | 170 | 76 | 5 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.11e-05 | 171 | 76 | 5 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.11e-05 | 171 | 76 | 5 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.24e-05 | 175 | 76 | 5 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | mild-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.28e-05 | 176 | 76 | 5 | 59a9c262c252b7d220a025837922d98e9d6b0a24 | |
| ToppCell | Leuk-UTI-Other-RBC|Leuk-UTI / Disease, Lineage and Cell Type | 1.62e-05 | 185 | 76 | 5 | 5b5dd856d6efc0539d92533cff134bbc3f98be45 | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 1.62e-05 | 185 | 76 | 5 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | Leuk-UTI-Other|Leuk-UTI / Disease, Lineage and Cell Type | 1.62e-05 | 185 | 76 | 5 | 895e8087e97ac0eab3446385e6e0dd24bea7f42c | |
| ToppCell | control-Myeloid-pDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.67e-05 | 186 | 76 | 5 | fe31e9cf4575ee40b50489593c51d8c36c3cc532 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.67e-05 | 186 | 76 | 5 | fccee4cfcc887358cf916d974f29627095b5ad9c | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-05 | 188 | 76 | 5 | 89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-05 | 188 | 76 | 5 | de6a270b6e4fe09c39a52c296632d86ada98465b | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.75e-05 | 188 | 76 | 5 | 879054b780378ae05be68e597c77c931bf0ade03 | |
| ToppCell | PBMC-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.80e-05 | 189 | 76 | 5 | 209cae68d78c8f72479b169e27c3ff7e143adece | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.80e-05 | 189 | 76 | 5 | a9ad1fb12304541f909dd0eeac9b9eb28c31fd41 | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 1.80e-05 | 189 | 76 | 5 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | PBMC-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.80e-05 | 189 | 76 | 5 | 98ca646231fbd5f29827c2dd31ac4503026bad7d | |
| ToppCell | (011)_pDC|World / immune cells in Peripheral Blood (logTPM normalization) | 1.89e-05 | 191 | 76 | 5 | d82ac4f6d9863734e09bf3cb71c1354a49b66b4f | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.89e-05 | 191 | 76 | 5 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.99e-05 | 193 | 76 | 5 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-05 | 195 | 76 | 5 | d8fa96c8f14bd088c3f8bd14f894a2c5b7ad46a7 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.09e-05 | 195 | 76 | 5 | dabf667875ed48fdce4f803f5ead39c71a6df42b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-05 | 197 | 76 | 5 | 89fe4885efc8db142c0dc0506840ae8aceba9ef9 | |
| ToppCell | distal-Hematologic-Alveolar_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.25e-05 | 198 | 76 | 5 | e1dc5a56fc23d3b1b4350d7162acec5762115b64 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid-Microglia|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.25e-05 | 198 | 76 | 5 | c0d33629438504a1545e07f0e5af2e76f50fd55b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.25e-05 | 198 | 76 | 5 | 2b93995f66c7352acc25d6c71d025b847881dacd | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 199 | 76 | 5 | 4e552015989defc32fe9068e0ba28521b2a1a09c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.30e-05 | 199 | 76 | 5 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 199 | 76 | 5 | 42d57522aa05892f37790d0039d936e065565359 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.30e-05 | 199 | 76 | 5 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 2.30e-05 | 199 | 76 | 5 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 2.30e-05 | 199 | 76 | 5 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.30e-05 | 199 | 76 | 5 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.30e-05 | 199 | 76 | 5 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.30e-05 | 199 | 76 | 5 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 199 | 76 | 5 | 0554f41ae53c275c92fe692bd999d7578d244fce | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 2.30e-05 | 199 | 76 | 5 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.30e-05 | 199 | 76 | 5 | 3ba48a4715d5e9387650aa97e0c5d7f7897bf380 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.36e-05 | 200 | 76 | 5 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.36e-05 | 200 | 76 | 5 | 01d707c4f8ee0daac635b7260937b1baebc6fc23 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.36e-05 | 200 | 76 | 5 | a1503bcc774bed9563eda7cf90b8b5bf4405ad85 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.36e-05 | 200 | 76 | 5 | 25247f8b6ba6cd899ba6bd47e28e090d697e4632 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.36e-05 | 200 | 76 | 5 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.36e-05 | 200 | 76 | 5 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-05 | 200 | 76 | 5 | 3cfb28299a55fc1c150262a7333c59a48ae65ad1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.99e-05 | 118 | 76 | 4 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | |World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-05 | 121 | 76 | 4 | da8fe561dcf50792d0cbcaad383d564f900a6677 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.17e-05 | 134 | 76 | 4 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-05 | 138 | 76 | 4 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 142 | 76 | 4 | 67d4ff3483ae34f77c3325aa0fbd3462ca19ade4 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 145 | 76 | 4 | 9b69bfdbf91ef197b4c483617aa67498d9d2cd79 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 145 | 76 | 4 | 31af9fce1dcd7e8ae1604476598e099232017ee9 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 145 | 76 | 4 | 76f0cde9acdc3ad5948c007dccf312665972c9e6 | |
| ToppCell | Int-URO-Other|Int-URO / Disease, Lineage and Cell Type | 1.30e-04 | 151 | 76 | 4 | ea5f25842e621be41a6491c9959d419d9cc7ebd6 | |
| ToppCell | Int-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type | 1.30e-04 | 151 | 76 | 4 | 0344d482f1c55c9eaa15beb8d6bac1c6cdca21b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 157 | 76 | 4 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 157 | 76 | 4 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 157 | 76 | 4 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.54e-04 | 158 | 76 | 4 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-04 | 159 | 76 | 4 | 6599707107083af6da092fe8984afc8fd89d2bb8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.58e-04 | 159 | 76 | 4 | 916d070d099726f22deb71966efccff00f8ea071 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 160 | 76 | 4 | 8308ca6f37986c526432a0fbc5f7ec2e75cfb6d7 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-04 | 161 | 76 | 4 | 76c993a4533362db2250c88b3ee3ede55362d54e | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 1.66e-04 | 161 | 76 | 4 | 283012858e575c70d09950de53da041509f59bfa | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 162 | 76 | 4 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 162 | 76 | 4 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 63 | 76 | 3 | e1b68ef6123ad084ce602b09fd1ba394785797e5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 63 | 76 | 3 | 9bfd9ba1335a155ed9e56dd41dd3621b37d4234e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tmem132c_(SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 63 | 76 | 3 | 9a90c761898618fc7e5e2984baa1021b74d4ac39 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|metastatic_Brain / Location, Cell class and cell subclass | 1.78e-04 | 164 | 76 | 4 | 06db4cc064f0765c481ce880207823872c27bfa9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_PSRC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-04 | 165 | 76 | 4 | 6de69b75174731931e7e80a3488f983a7ba4defe | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 165 | 76 | 4 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | Int-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type | 1.82e-04 | 165 | 76 | 4 | 9803c3db6cdcf925bea7d9c382bf4fd05acf3509 | |
| ToppCell | severe-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.86e-04 | 166 | 76 | 4 | ae38850fde549b8dd6fb12f0ef80b428ade50485 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 167 | 76 | 4 | 1e2fc1637769405a61f4c7e44945712a1888a299 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.95e-04 | 168 | 76 | 4 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.95e-04 | 168 | 76 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.95e-04 | 168 | 76 | 4 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 170 | 76 | 4 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 2.09e-04 | 171 | 76 | 4 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 171 | 76 | 4 | 246fc7edcefc47437d1df6029f295aca3b34b2b2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 171 | 76 | 4 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 171 | 76 | 4 | 1fb4e11f92b48dc2d6e553c22e2571bbd8c223c6 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 2.14e-04 | 172 | 76 | 4 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.14e-04 | 172 | 76 | 4 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | lymphoid-B_cell-pro-B|B_cell / Lineage, cell class and subclass | 2.14e-04 | 172 | 76 | 4 | da1e2e54f442f5c2032c857c4812e9060f2053cd | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 172 | 76 | 4 | a03f30a996a9474ad4cccd209476423a042df002 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 172 | 76 | 4 | f92a53ad2e464cd68ba1714bcc1d5911479cdf1c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.14e-04 | 172 | 76 | 4 | 1215f61f115b042f84721b64c2ed1f48081535f1 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 2.14e-04 | 172 | 76 | 4 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-04 | 173 | 76 | 4 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| Drug | Potassium Chloride | 1.71e-09 | 6 | 76 | 4 | DB00761 | |
| Drug | Bumetanide | 2.02e-07 | 16 | 76 | 4 | ctd:D002034 | |
| Drug | furosemide | 3.50e-06 | 272 | 76 | 8 | CID000003440 | |
| Drug | DCPIB | 5.79e-06 | 11 | 76 | 3 | CID010071166 | |
| Drug | ((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid | 1.10e-05 | 2 | 76 | 2 | ctd:C095651 | |
| Drug | Furosemide | 1.84e-05 | 164 | 76 | 6 | ctd:D005665 | |
| Disease | 4-hydroxyphenylacetylglutamine measurement | 1.71e-05 | 3 | 71 | 2 | EFO_0800688 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.03e-04 | 9 | 71 | 2 | C0085548 | |
| Disease | myeloid cell surface antigen CD33 measurement | 5.87e-04 | 15 | 71 | 2 | EFO_0008238 | |
| Disease | Benign Neoplasm | 5.98e-04 | 68 | 71 | 3 | C0086692 | |
| Disease | Neoplasms | 5.98e-04 | 68 | 71 | 3 | C0027651 | |
| Disease | epilepsy (implicated_via_orthology) | 6.54e-04 | 163 | 71 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, body mass index | 6.70e-04 | 16 | 71 | 2 | EFO_0004340, EFO_0006336 | |
| Disease | glaucoma (is_marker_for) | 1.05e-03 | 20 | 71 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Schizophrenia | 1.25e-03 | 883 | 71 | 8 | C0036341 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.27e-03 | 195 | 71 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Renal glomerular disease | 1.40e-03 | 23 | 71 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.40e-03 | 23 | 71 | 2 | C4521256 | |
| Disease | Ciliopathies | 2.40e-03 | 110 | 71 | 3 | C4277690 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WQAGTTPWNIFPVIS | 331 | P56817 | |
| VWDVSTETCVPLPWF | 271 | Q9NRG9 | |
| FNTIWKPWLQPCCGT | 531 | Q5FYA8 | |
| TWFVSWNPCLPCVVK | 101 | Q96AK3 | |
| FQITWFVSWTPCPDC | 86 | Q9UH17 | |
| QPQWVTGPWLACSRT | 876 | Q9UNA0 | |
| PPCPQTWRSLWIGYS | 1586 | P53420 | |
| VVWGPSASVAPNAWS | 571 | P98082 | |
| SKNWWNCIVTTHGPP | 216 | Q6P3S6 | |
| ELVCTAPQWVPVSWV | 911 | O14936 | |
| GPVITWHNPVTIWCQ | 36 | P59901 | |
| AQLCAWPWPTDVLTG | 46 | P46199 | |
| VVPCGTPWGQWYQTL | 11 | Q8WVJ2 | |
| ALVPWGCPWTQAEGT | 146 | Q02846 | |
| VNVSCPWYLPWASSV | 81 | P43220 | |
| FSSCPSGSIQWIWDV | 11 | Q6ZP29 | |
| SWACEQGTPPIFSWL | 166 | P20138 | |
| DWWAQQPSTGVPLVT | 176 | Q02556 | |
| VGQYTVQWPGTWCFI | 196 | P43115 | |
| TIFSSAWWVPPCCGT | 121 | O15503 | |
| PWGPCELWVTASTIA | 481 | Q6UWB1 | |
| PNCTIPGLWTWLRNS | 66 | P23219 | |
| PAAQQVSPEWIWACI | 986 | P49916 | |
| ICCTIWVLVWTGSIP | 141 | Q9Y2T6 | |
| SQQPLVWPAWVYCTR | 266 | Q05925 | |
| SCGLSFPWPEQVWFK | 196 | P48146 | |
| HIWIPSSWCSLTEGP | 81 | Q6UXL0 | |
| SVENLCTVIWTWNPP | 41 | P78552 | |
| CTVIWTWNPPEGASS | 46 | P78552 | |
| WIPTGLCWSWIPITS | 931 | Q96JM4 | |
| IIGWGTPTVCVTVWA | 271 | P41586 | |
| WFPGFPVATVQTTWL | 136 | Q9H208 | |
| VVGCLPWAWSSKPNS | 691 | Q08828 | |
| SVWACASFQELWPSP | 71 | P41002 | |
| WPGQVVICVSSIFWT | 1281 | Q8TD57 | |
| PVSCSWFLWRQPGEF | 31 | Q5T197 | |
| VLTCTPWGAPIIWDG | 71 | U3KPV4 | |
| SWSKWSSPVCVPPEN | 221 | P42701 | |
| PAQVGDSFGPTWWTC | 66 | Q9NTJ4 | |
| CISPGNIWTPLWEEL | 181 | Q9BPX1 | |
| RWTVPATCPQPWRYT | 471 | O14682 | |
| DQACSSPQWVPVSWV | 451 | Q00013 | |
| LGYSQPWIQVPTSWV | 296 | A6NKP2 | |
| WPSPWVIVIGSFFST | 566 | Q9UHW9 | |
| WPSPWVIVIGSFFST | 501 | Q9Y666 | |
| TLAWPSPWVIVIGSF | 501 | Q9H2X9 | |
| PIIGSWFWTRVEACV | 611 | Q5JY77 | |
| WTWPFNTPVALPRCS | 81 | Q11128 | |
| TVENSQWSLWPEIPC | 41 | A5PLK6 | |
| HTVCGTEVFGWTPWT | 2766 | A2VEC9 | |
| SFVSVLPWGSCNNPW | 301 | Q9Y345 | |
| SVNVETCPPAWRLWP | 651 | Q7Z494 | |
| VPWEPGTWLISCQVN | 336 | Q9BQS7 | |
| SCSFHGIPTPSVQWW | 26 | Q8N7X8 | |
| IGILWPVFTSEPNQW | 3241 | P08F94 | |
| VWTTQPWTIPANEAV | 296 | Q9NSE4 | |
| WPPPEQWCKQLFSSV | 211 | Q9NP71 | |
| WPSPWVIVIGSFFST | 501 | Q9UP95 | |
| SQNPISCFEWWFPGI | 41 | Q53R12 | |
| IWTLVEPWTAGCTVF | 276 | Q08AH1 | |
| ASTPVPGSPWCVVWT | 336 | Q5VWI1 | |
| TPWSPAVVEKWFPFC | 486 | Q7Z2Z1 | |
| AGQDPSCVWVGWVTP | 1336 | Q15413 | |
| FLTIWTTVVANPGQW | 291 | Q9GZP7 | |
| FSPSVIIILVPCWWH | 71 | Q6UWF5 | |
| TPLSPCFVEHVSWWA | 121 | A8MV23 | |
| NTPCPVPIFWASWGS | 716 | Q9P283 | |
| TPWNTAIPLPSCWDQ | 81 | Q9NPB0 | |
| WDCIVQTWPAIVSSG | 1046 | Q14997 | |
| PETQEALCPQVTWSW | 286 | Q93038 | |
| ALCPQVTWSWDQLPS | 291 | Q93038 | |
| SCTPSWFWGPVVTLE | 526 | Q9Y2K6 | |
| IVSGIWALLCVWQTP | 56 | Q96CP7 | |
| WPVPAFDIITQWCFE | 1706 | Q6ZT12 | |
| VPTWWTVGGALCVVA | 336 | Q2M3R5 | |
| CNTDPGSPWSIRFTW | 236 | O15016 | |
| KRFVVSCVPSWFWGP | 551 | Q8TEY7 | |
| SCVPSWFWGPVVTLQ | 556 | Q8TEY7 | |
| PRWFPQPTVVWASQV | 171 | Q7Z7D3 | |
| PWPVWAQVSATASPS | 21 | Q2I0M4 |